These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 16316482)
41. A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder. Bielski RJ; Bose A; Chang CC Ann Clin Psychiatry; 2005; 17(2):65-9. PubMed ID: 16075658 [TBL] [Abstract][Full Text] [Related]
42. Citalopram and escitalopram in the treatment of major depressive disorder: a pooled analysis of 3 clinical trials. Li H; Li T; Li G; Luo J Ann Clin Psychiatry; 2014 Nov; 26(4):281-7. PubMed ID: 25401715 [TBL] [Abstract][Full Text] [Related]
43. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. Stein DJ; Ahokas A; Márquez MS; Höschl C; Oh KS; Jarema M; Avedisova AS; Albarran C; Olivier V J Clin Psychiatry; 2014 Apr; 75(4):362-8. PubMed ID: 24569045 [TBL] [Abstract][Full Text] [Related]
46. A prospective study of escitalopram in the treatment of major depressive episodes in the presence or absence of anxiety. Olié JP; Tonnoir B; Ménard F; Galinowski A Depress Anxiety; 2007; 24(5):318-24. PubMed ID: 17041922 [TBL] [Abstract][Full Text] [Related]
47. A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder. Strawn JR; Moldauer L; Hahn RD; Wise A; Bertzos K; Eisenberg B; Greenberg E; Liu C; Gopalkrishnan M; McVoy M; Knutson JA J Child Adolesc Psychopharmacol; 2023 Apr; 33(3):91-100. PubMed ID: 37074330 [No Abstract] [Full Text] [Related]
48. Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability. Montgomery S; Emir B; Haswell H; Prieto R Curr Med Res Opin; 2013 Oct; 29(10):1223-30. PubMed ID: 23808960 [TBL] [Abstract][Full Text] [Related]
49. Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensions. Stein DJ; Andersen EW; Lader M Eur Neuropsychopharmacol; 2006 Jan; 16(1):33-8. PubMed ID: 16014329 [TBL] [Abstract][Full Text] [Related]
50. Escitalopram versus placebo in the treatment of dysthymic disorder. Hellerstein DJ; Batchelder ST; Hyler S; Arnaout B; Toba C; Benga I; Gangure D Int Clin Psychopharmacol; 2010 May; 25(3):143-8. PubMed ID: 21811192 [TBL] [Abstract][Full Text] [Related]
52. Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder. Schmitt L; Tonnoir B; Arbus C Neuropsychobiology; 2006; 54(4):201-7. PubMed ID: 17337913 [TBL] [Abstract][Full Text] [Related]
53. Treatment of comorbid anxiety and depression with escitalopram: results of a post-marketing surveillance study. Laux G; Friede M; Müller WE Pharmacopsychiatry; 2013 Jan; 46(1):16-22. PubMed ID: 22648305 [TBL] [Abstract][Full Text] [Related]
54. Comparison of escitalopram and paroxetine in the treatment of major depressive disorder. Lin HL; Hsu YT; Liu CY; Chen CH; Hsiao MC; Liu YL; Shen WW; Hsiao CF; Liu SI; Chang LH; Tang HS; Lai HL; Lin PS; Lin KM; Tsou HH Int Clin Psychopharmacol; 2013 Nov; 28(6):339-45. PubMed ID: 23881184 [TBL] [Abstract][Full Text] [Related]
55. Escitalopram for the treatment of GAD: efficacy across different subgroups and outcomes. Stein DJ; Andersen HF; Goodman WK Ann Clin Psychiatry; 2005; 17(2):71-5. PubMed ID: 16075659 [TBL] [Abstract][Full Text] [Related]
57. Escitalopram: a review of its use in the management of anxiety disorders. Dhillon S; Scott LJ; Plosker GL CNS Drugs; 2006; 20(9):763-90. PubMed ID: 16953656 [TBL] [Abstract][Full Text] [Related]
58. Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults. Wetherell JL; Petkus AJ; White KS; Nguyen H; Kornblith S; Andreescu C; Zisook S; Lenze EJ Am J Psychiatry; 2013 Jul; 170(7):782-9. PubMed ID: 23680817 [TBL] [Abstract][Full Text] [Related]
59. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial. Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875 [TBL] [Abstract][Full Text] [Related]
60. Efficacy of vortioxetine in working patients with generalized anxiety disorder. Christensen MC; Loft H; Florea I; McIntyre RS CNS Spectr; 2019 Apr; 24(2):249-257. PubMed ID: 29081307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]